Molecular Basis of Disease 1992 - 1993: Vol 1180 Index

4 Pages·1.5 MB·English

Author Index
Adebiyi, L.A. Y., see Cook, E.B. (1180) 207 David, L.L., see Azuma, M. (1180) 215
Alcolado, J.C., see Thorn, J.A. (1180) 299 Davidson, M.H., see Lands, W.E.M. (1180) 147
Amiconi, G., see Lendaro, E. (1180) 15 De Abreu, R.A., see Stet, E.H. (1180) 277
Andresen, B.S., see Jensen, T.G. (1180) 65 Dean, R.T., see Jessup, W. (1180) 73
Arahata, K., see Koga, R. (1180) 257 Deroussent, A., see Dray, F. (1180) 83
Azuma, M., David, L.L. and Shearer, T.R. DiMauro, S., see Simonetti, S. (1180) 113
Superior prevention of calcium ionophore cataract by E64d (1180) Divoky, V., Bissé, E., Wilson, J.B., Gu, L.-H., Wieland, H., Hein-
215 richs, I., Prior, J.F. and Huisman, T.H.J.
Heterozygosity for the IVS-I-5 (G — C) mutation with a G>A
change at codon 18 (Val — Met; Hb Baden) in cis anda T>G
Baba, S., Takahashi, T., Kasama, T. and Shirasawa, H.
mutation at codon 126 (Val — Gly; Hb Dhonburi) in trans result-
Identification of two novel amyloid A protein subsets coexisting
ing in a thalassemia intermedia (1180) 173
in an individual patient of AA-amyloidosis (1180) 195
Dodelson de Kremer, R., see Brown, C.A. (1180) 91
Backer, A.E., see Holgersson, J. (1180) 33
Dray, F., Normand, B.V.-L., Deroussent, A., Briquet, I., Gabellec,
Bagnara, A.S., McDonald, L.E. and Slade, H.M.
M.-M., Nakamura, S., Wahl, L.M., Gouyette, A. and Salahuddin,
Deoxyadenosine toxicity in an adenosine deaminase-inhibited
raeF
human CCRF-CEM T-lymphoblastoid cell line causes cell swelling
Active metabolism of arachidonic acid by Kaposi sarcoma cells
(1180) 163
cultured from lung biopsies (KS-3); identification by HPLC and
Bechara, E.J.H., see Hermes-Lima, M. (1180) 201
MS/MS of the predominant metabolite secreted as the 11,12-
Bellelli, A., see Lendaro, E. (1180) 15
epoxy-eicosatrienoic acid (1180) 83
Bertrand, C., Largilli¢re, C., Zabot, M.T., Mathieu, M. and Vianey-
Saban, C. Edmonds, S., see Gibb, A.L. (1180) 313
Very long chain acyl-CoA dehydrogenase deficiency: identifica-
Eleftheriou, C.S., Trakas, N., Kokla, A. and Tzartos, S.J.
tion of a new inborn error of mitochondrial fatty acid oxidation in A group of three fibroblast secreted polypeptides suppressed by
fibroblasts (1180) 327 cellular ageing and interferon-gamma (1180) 304
Bevers, E.M., see Zwaal, R.F.A. (1180) 1
Emly, J.F., Ratcliffe, W.A., Green, E., Bowden, S.J., Heath, D.A.,
Bissé, E., see Divoky, V. (1180) 173 Blight, A., Hughes, S. and Ratcliffe, J.G.
Blight, A., see Emly, J.F. (1180) 58 Immunochemical characterisation of parathyroid hormone-re-
Bokkerink, J.P.M., see Stet, E.H. (1180) 277 lated protein from tumour and non-tumour cells (1180) 58
Bolund, L., see Jensen, T.G. (1180) 65 Enghild, J.J., see Gonzalez-Gronow, M. (1180) 283
Borras, T., see Rodriguez, I.R. (1180) 44
Bowden, S.J., see Emly, J.F. (1180) 58 Felipo, V., see Kosenko, E. (1180) 321
Bowen, P., see Lands, W.E.M. (1180) 147 Fellowes, A.P., see Peach, R.J. (1180) 107
Brancaccio, A., see Lendaro, E. (1180) 15 Ferrao, A.V. and Mason, R.M.
Breimer, M.E., see Holgersson, J. (1180) 33 The effect of heparin on cell proliferation and type-I collagen
Brennan, S.O., see Peach, R.J. (1180) 107 synthesis by adult human dermal fibroblasts (1180) 225
Briquet, I., see Dray, F. (1180) 83 Finelli, C., Guarnieri, C., Muscari, C., Ventura, C. and Caldarera,
Bross, P., see Jensen, T.G. (1180) 65 C.M.
Brown, C.A., McInnes, B., Dodelson de Kremer, R. and Mahuran, Incorporation of ['*C]hypoxanthine into cardiac adenine nu-
D.J. cleotides: effect of aging and post-ischemic reperfusion (1180)
Characterization of two HEXB gene mutations in Argentinean 262
patients with Sandhoff disease (1180) 91 Fisher, M.J., see Green, A.K. (1180) 21
Brunori, M., see Lendaro, E. (1180) 15 Freeman, A.M., see Gibb, A.L. (1180) 313
Burns, J.H., see Lands, W.E.M. (1180) 147
Gabellec, M.-M., see Dray, F. (1180) 83
Galacteros, F., see Wajcman, H. (1180) 53
Caldarera, C.M., see Finelli, C. (1180) 262 Galton, D., see Thorn, J.A. (1180) 299
Castello, C., see Lendaro, E. (1180) 15 Gattegno, L., see Mbemba, E. (1180) 123
Castilho, R.F., see Hermes-Lima, M. (1180) 201 George, P.M., see Peach, R.J. (1180) 107
Chamberlain, J.C., see Thorn, J.A. (1180) 299 Gibb, A.L., Freeman, A.M., Smith, R.A.G., Edmonds, S. and Sim, E.
Chen, X., see Simonetti, S. (1180) 113 The interaction of soluble human complement receptor type 1
Comfurius, P., see Zwaal, R.F.A. (1180) 1 (sCR1, BRL55730) with human complement component C4 (1180)
Cook, E.B., Adebiyi, L.A.Y., Preedy, V.R., Peters, T.J. and Palmer, 313
T.N. Gieseg, S.P., see Jessup, W. (1180) 73
Chronic effects of ethanol on muscle metabolism in the rat (1180) Gonzalez-Gronow, M., Enghild, J.J. and Pizzo, S.V.
207 Streptokinase and human fibronectin share a common epitope:
Cooper, S.T., see Thompson, M.P. (1180) 236 implications for regulation of fibrinolysis and rheumatoid arthritis
Czyrski, J.A., see Mbemba, E. (1180) 123 (1180) 283
Gonzalez, P., see Rodriguez, I.R. (1180) 44 Kokla, A., see Eleftheriou, C.S. (1180) 304
Gouyette, A., see Dray, F. (1180) 83 Kglvraa, S., see Jensen, T.G. (1180) 65
Green, A.K., McDowall, I.L., Richardson, S.-C.B. and Fisher, M.J. Konishi, Y., see Matsuda, S. (1180) 243
The effect of vanadate upon the expression of phenylalanine Kosenko, E., Kaminsky, Y.G., Felipo, V., Minana, M.-D. and
hydroxylase in streptozotocin-diabetic rat liver (1180) 21 Grisolia, S.
Green, E., see Emly, J.F. (1180) 58 Chronic hyperammonemia prevents changes in brain energy and
Gregersen, N., see Jensen, T.G. (1180) 65 ammonia metabolites induced by acute ammonium intoxication
Grisolia, S., see Kosenko, E. (1180) 321 (1180) 321
Gu, L.-H., see Divoky, V. (1180) 173 Kramer, N.C., see Lands, W.E.M. (1180) 147
Guarnieri, C., see Finelli, C. (1180) 262
Gupta, R.K., see Schanne, F.A.X. (1180) 187
Labelle, Y., Puymirat, J. and Tanguay, R.M.
Gustavsson, M.L., see Holgersson, J. (1180) 33
Localization of cells in the rat brain expressing fumarylacetoac-
etate hydrolase, the deficient enzyme in hereditary tyrosinemia
Heath, D.A., see Emly, J.F. (1180) 58
type 1 (1180) 250
Heinrichs, I., see Divoky, V. (1180) 173
Lahary, A., see Wajcman, H. (1180) 53
Hermes-Lima, M., Castilho, R.F., Valle, V.G.R., Bechara, E.J.H.
Lands, W.E.M., Libelt, B., Morris, A., Kramer, N.C., Prewitt, T.E.,
and Vercesi, A.E.
Bowen, P., Schmeisser, D., Davidson, M.H. and Burns, J.H.
Calcium-dependent mitochondrial oxidative damage promoted by
Maintenance of lower proportions of (n — 6) eicosanoid precur-
5-aminolevulinic acid (1180) 201
sors in phospholipids of human plasma in response to added
Herz, F.
dietary (n — 3) fatty acids (1180) 147
Divergent effects of butyrate on the alkaline phosphatases of
Largilliére, C., see Bertrand, C. (1180) 327
SW-620 cells (1180) 289
Lazo, O., see Singh, I. (1180) 221
Heymans, H.S.A., see Niezen-Koning, K.E. (1180) 28
Lendaro, E., Ippoliti, R., Brancaccio, A., Bellelli, A., Vallone, B.,
Holgersson, J., Backer, A.E., Breimer, M.E., Gustavsson, M.L., Jo-
Ivaldi, G., Sciarratta, G.V., Castello, C., Tomova, S., Brunori, M.
vall, P.-A., Karlsson, H., Pimlott, W. and Samuelsson, B.E.
and Amiconi, G.
The blood group B type-4 heptaglycosylceramide is a minor blood
Hemoglobin Dallas (@97(G4)Asn — Lys): functional characteriza-
group B structure in human B kidneys in contrast to the corre-
tion of a high oxygen affinity natural mutant (1180) 15
sponding A type-4 compound in A kidneys. Structural and in
Leung, B.S., see Zhou, L. (1180) 130
vitro biosynthetic studies (1180) 33
Libelt, B., see Lands, W.E.M. (1180) 147
Holme, E., see Jensen, T.G. (1180) 65
Low, S.Y., see Hundal, H.S. (1180) 137
Hughes, S., see Emly, J.F. (1180) 58
Huisman, T.H.J., see Divoky, V. (1180) 173
Hundal, H.S., Taylor, P.M., Willhoft, N.M., Mackenzie, B., Low, Mackenzie, B., see Hundal, H.S. (1180) 137
S.Y., Ward, M.R. and Rennie, M.J. Mahuran, D.J., see Brown, C.A. (1180) 91
A role for membrane transport in modulation of intramuscular Majamaa, K., see Tarkka, T. (1180) 294
free glutamine turnover in streptozotocin diabetic rats (1180) 137 Makinose, Y., see Semba, U. (1180) 267
Mannermaa, R.-M., see Tarkka, T. (1180) 294
IJlst, L., see Niezen-Koning, K.E. (1180) 28 Marden, M., see Wajcman, H. (1180) 53
Ippoliti, R., see Lendaro, E. (1180) 15
Mason, R.M., see Ferrao, A.V. (1180) 225
Ishiura, S., see Koga, R. (1180) 257 Mathieu, M., see Bertrand, C. (1180) 327
Ivaldi, G., see Lendaro, E. (1180) 15 Matsuda, S., Murakami, J.. Yamamoto, Y., Konishi, Y., Yokoyama,
C., Yoshimoto, T., Yamamoto, S., Mimura, Y. and Okuma, M.
Janssen, Y.P.G., see Stet, E.H. (1180) 277
Decreased messenger RNA of arachidonate 12-lipoxygenase in
Jeffery, L.J., see Williams, D.H. (1180) 9
platelets of patients with myeloproliferative disorders (1180) 243
Jensen, T.G., Andresen, B.S., Bross, P., Jensen, U.B., Holme, E.,
Matsuzaki, T., see Koga, R. (1180) 257
Kglvraa, S., Gregersen, N. and Bolund, L.
Mbemba, E., Czyrski, J.A. and Gattegno, L.
Expression of wild-type and mutant medium-chain acyl-CoA de-
The interaction of a glycosaminoglycan, heparin, with HIV-1
hydrogenase (MCAD) cDNA in eucaryotic cells (1180) 65
major envelope glycoprotein (1180) 123
Jensen, U.B., see Jensen, T.G. (1180) 65
McDonald, LE., see Bagnara, A.S. (1180) 163
Jessup, W., Mohr, D., Gieseg, S.P., Dean, R.T. and Stocker, R. McDowall, I.L., see Green, A.K. (1180) 21
The participation of nitric oxide in cell free- and its restriction of
McInnes, B., see Brown, C.A. (1180) 91
macrophage-mediated oxidation of low-density lipoprotein (1180)
Mimnaugh, E.G., see Monti, E. (1180) 231
73
Mimura, Y., see Matsuda, S. (1180) 243
Jovall, P.-A., see Holgersson, J. (1180) 33
Minana, M.-D., see Kosenko, E. (1180) 321
Mizumoto, K., see Takami, M. (1180) 180
Kadenbach, B., see Zimmermann, P. (1180) 99
Mohr, D., see Jessup, W. (1180) 73
Kalipada, P., see Singh, I. (1180) 221
Monconduit, M., see Wajcman, H. (1180) 53
Kamakura, K., see Koga, R. (1180) 257
Monti, E., Mimnaugh, E.G. and Sinha, B.K.
Kambara, T., see Semba, U. (1180) 267
Synergistic interactions of etoposide and interleukin-la are not
Kaminsky, Y.G., see Kosenko, E. (1180) 321
due to DNA damage in human melanoma cells (1180) 231
Karlsson, H., see Holgersson, J. (1180) 33
Morris, A., see Lands, W.E.M. (1180) 147
Kasama, T., see Baba, S. (1180) 195
Murakami, J., see Matsuda, S. (1180) 243
Kino, K., see Takami, M. (1180) 180
Murray, E.J., see Williams, D.H. (1180) 9
Kister, J., see Wajcman, H. (1180) 53
Muscari, C., see Finelli, C. (1180) 262
Koga, R., Ishiura, S., Takemitsu, M., Kamakura, K., Matsuzaki, T.,
Arahata, K., Nonaka, I. and Sugita, H.
Immunoblot analysis of dystrophin-related protein (DRP) (1180) Nagel, G.T., see Niezen-Koning, K.E. (1180) 28
257 Nakamura, S., see Dray, F. (1180) 83
338
Niezen-Koning, K.E., Wanders, R.J.A., Nagel, G.T., IJlst, L. and Sone, T., see Takami, M. (1180) 180
Heymans, H.S.A. Stet, E.H., De Abreu, R.A., Janssen, Y.P.G., BOkkerink, J.P.M. and
A new, simple assay for long-chain acyl-CoA dehydrogenase in Trijbels, F.J.M.
cultured skin fibroblasts using stable isotopes and GC-MS (1180) A biochemical basis for synergism of 6-mercaptopurine and my-
28 cophenolic acid in Molt F4, a human malignant T-lymphoblastic
Nishino, N., see Semba, U. (1180) 267 cell line (1180) 277
Nonaka, I., see Koga, R. (1180) 257 Stocker, R., see Jessup, W. (1180) 73
Normand, B.V.-L., see Dray, F. (1180) 83 Stocks, J., see Thorn, J.A. (1180) 299
Sugita, H., see Koga, R. (1180) 257
Oikarinen, J., see Tarkka, T. (1180) 294
Okabe, H., see Semba, U. (1180) 267 Takahashi, T., see Baba, S. (1180) 195
Okuma, M., see Matsuda, S. (1180) 243 Takami, M., Sone, T., Mizumoto, K., Kino, K. and Tsunoo, H.
Maleylated human serum albumin inhibits HIV-1 infection in
vitro (1180) 180
Palmer, T.N., see Cook, E.B. (1180) 207
Takemitsu, M., see Koga, R. (1180) 257
Parry, B.R., see Thompson, M.P. (1180) 236
Tanase, S., see Semba, U. (1180) 267
Peach, R.J., Fellowes, A.P., Brennan, S.O. and George, P.M.
Tanguay, R.M., see Labelle, Y. (1180) 250
Albumin Rugby Park: a truncated albumin variant caused by a
Tarkka, T., Yli-Mayry, N., Mannermaa, R.-M., Majamaa, K. and
G > C splice-site mutation in intron 13 (1180) 107
Oikarinen, J.
Peters, T.J., see Cook, E.B. (1180) 207
Specific non-enzymatic glycation of the rat histone H1 nucleotide
Pimlott, W., see Holgersson, J. (1180) 33
binding site in vitro in the presence of AIF, .A putative mecha-
Pizzo, S.V., see Gonzalez-Gronow, M. (1180) 283
nism for impaired chromatin function (1180) 294
Preedy, V.R., see Cook, E.B. (1180) 207
Taylor, P.M., see Hundal, H.S. (1180) 137
Prewitt, T.E., see Lands, W.E.M. (1180) 147
Thompson, M.P., Cooper, S.T., Parry, B.R. and Tuckey, J.A.
Prior, J.F., see Divoky, V. (1180) 173
Increased expression of the mRNA for hormone-sensitive lipase
Puymirat, J., see Labelle, Y. (1180) 250
in adipose tissue of cancer patients (1180) 236
Thorn, J.A., Stocks, J., Reichl, D., Alcolado, J.C., Chamberlain, J.C.
Ratcliffe, J.G., see Emly, J.F. (1180) 58 and Galton, D.
Ratcliffe, W.A., see Emly, J.F. (1180) 58 Variability of plasma apolipoprotein (apo) A-II levels associated
Reichl, D., see Thorn, J.A. (1180) 299 with an apo A-II gene polymorphism in monozygotic twin pairs
Rennie, M.J., see Hundal, H.S. (1180) 137 (1180) 299
Richardson, S.-C.B., see Green, A.K. (1180) 21 Tomova, S., see Lendaro, E. (1180) 15
Rodriguez, I.R., Gonzalez, P., Zigler, Jr., J.S. and Borras, T. Trakas, N., see Eleftheriou, C.S. (1180) 304
A guinea-pig hereditary cataract contains a splice-site deletion in Trijbels, F.J.M., see Stet, E.H. (1180) 277
a crystallin gene (1180) 44 Tsunoo, H., see Takami, M. (1180) 180
Rosen, J.F., see Schanne, F.A.X. (1180) 187 Tuckey, J.A., see Thompson, M.P. (1180) 236
Tzartos, S.J., see Eleftheriou, C.S. (1180) 304
Salahuddin, Z.S., see Dray, F. (1180) 83
Samuelsson, B.E., see Holgersson, J. (1180) 33 Valle, V.G.R., see Hermes-Lima, M. (1180) 201
Schanne, F.A.X., Gupta, R.K. and Rosen, J.F. Vallone, B., see Lendaro, E. (1180) 15
Lead inhibits 1,25-dihyroxyyitamin D-3 regulation of calcium Ventura, C., see Finelli, C. (1180) 262
metabolism in osteoblastic osteosarcoma cells (ROS 17/2.8) Vercesi, A.E., see Hermes-Lima, M. (1180) 201
(1180) 187 Vianey-Saban, C., see Bertrand, C. (1180) 327
Schmeisser, D., see Lands, W.E.M. (1180) 147
Schon, E.A., see Simonetti, S. (1180) 113
Wahl, L.M., see Dray, F. (1180) 83
Sciarratta, G.V., see Lendaro, E. (1180) 15
Wajcman, H., Kister, J.,. Marden, M., Lahary, A., Monconduit, M.
Semba, U., Shibuya, Y., Tanase, S., Nishino, N., Makinose, Y.,
and Galacteros, F.
Kambara, T., Okabe, H. and Yamamoto, T.
Hemoglobin Rouen (a-140 (HC2) Tyr — His): alteration of the
Difference between human and guinea pig Hageman factors in
a-chain C-terminal region and moderate increase in oxygen affin-
activation by bacterial proteinases: cleavage site shift due to local
ity (1180) 53
amino acid substitutions may determine the activation efficiency
Wanders, R.J.A., see Niezen-Koning, K.E. (1180) 28
of serine proteinase zymogens (1180) 267
Ward, M.R., see Hundal, H.S. (1180) 137
Shearer, T.R., see Azuma, M. (1180) 215
Wieland, H., see Divoky, V. (1180) 173
Shibuya, Y., see Semba, U. (1180) 267
Willhoft, N.M., see Hundal, H.S. (1180) 137
Shirasawa, H., see Baba, S. (1180) 195
Williams, D.H., Jeffery, L.J. and Murray, E.J.
Sim, E., see Gibb, A.L. (1180) 313
Aurothioglucose inhibits induced NF-kB and AP-1 activity by
Simonetti, S., Chen, X., DiMauro, S. and Schon, E.A.
acting as an IL-1 functional antagonist (1180) 9
Accumulation of deletions in human mitochondrial DNA during
Wilson, J.B., see Divoky, V. (1180) 173
normal aging: analysis by quantitative PCR (1180) 113
Singh, A.K., see Singh, I. (1180) 221
Singh, I., Lazo, O., Kalipada, P. and Singh, A.K. Yamamoto, S., see Matsuda, S. (1180) 243
Phytanic acid a@-oxidation in human cultured skin fibroblasts Yamamoto, T., see Semba, U. (1180) 267
(1180) 221 Yamamoto, Y., see Matsuda, S. (1180) 243
Sinha, B.K., see Monti, E. (1180) 231 Yli-Mayry, N., see Tarkka, T. (1180) 294
Slade, H.M., see Bagnara, A.S. (1180) 163 Yokoyama, C., see Matsuda, S. (1180) 243
Smith, R.A.G., see Gibb, A.L. (1180) 313 Yoshimoto, T., see Matsuda, S. (1180) 243
339
Zabot, M.T., see Bertrand, C. (1180) 327 Zimmermann, P. and Kadenbach, B.
Zhou, L. and Leung, B.S. Modified structure and kinetics of cytochrome-c oxidase in fi-
Growth regulation of ovarian cancer cells by epidermal growth broblasts from patients with Leigh syndrome (1180) 99
factor and transforming growth factors a and #1 (1180) 130 Zwaal, R.F.A., Comfurius, P. and Bevers, E.M.
Zigler, Jr., J.S., see Rodriguez, I.R. (1180) 44 Platelet procoagulant activity and microvesicle formation. Its
putative role in hemostasis and thrombosis (1180) 1